News

Camposol Holding PLC: Key Q2 and H1 2025 Financial Insights

Camposol Holding PLC: Key Q2 and H1 2025 Financial Insights

Camposol Holding PLC: Key Financial Insights for 2025

Today, Camposol Holding PLC, a leading multinational dedicated to providing fresh and healthy food, shared its preliminary financial results for the second quarter that ended mid-year. The report was crafted in alignment with International Financial Reporting Standards (IFRS), although these numbers may be subject to revisions as the audited results become available.

First Half of 2025: A Snapshot

This half of the year reflected remarkable growth across various metrics. The volume sold reached 55,162 MT, which is an impressive 38% increase compared to the previous year. Furthermore, total sales soared to USD 222 million, demonstrating a 22% increase relative to 2024. EBITDA rose to USD 67 million, marking a 9% improvement compared to last year.

Net Earnings and Debt Ratio

However, net profit for the first half was reported at USD 16 million, which is a decline of 17% compared to the same period last year. Notably, Camposol maintained a strong Net Debt-to-EBITDA ratio of 2.59x, continuing a streak of four consecutive quarters below the critical threshold of 3.5x.

Highlights from the Second Quarter

In addition to robust financial figures, Camposol achieved several operational milestones during the second quarter:

Quality and Certification Achievements

Notably, the Chao plant secured an AA+ rating in the BRCGS audit. This level of recognition showcases the high standards Camposol maintains in food safety and quality. Furthermore, the organic certification for Camposol Fresh VB in the Netherlands has been successfully restored, highlighting the company's commitment to sustainability and quality assurance.

Commitment to Traceability

Demonstrating its dedication to operational integrity, Camposol was honored by BASC Peru, acknowledging 20 years of commitment to enhancing the traceability of its operations. This recognition marks the company's dedication to maintaining safety standards and operational excellence.

Laboratory Achievements

In a significant achievement, the Biotech Laboratory of Camposol crossed a milestone by delivering over one million plants, showcasing the innovation and growth inherent in its proprietary varieties.

Insights from the CEO

CEO Ricardo Naranjo voiced optimism about the financial results, stating, "The first half of 2025 confirmed the strength of our strategy and disciplined execution. With an EBITDA margin of 30%, we have demonstrated that our financial management is effective. Maintaining the Net Debt-to-EBITDA ratio at 2.59x emphasizes solid fiscal health, benefiting both the company and its stakeholders.”

Review of Product Segments

An in-depth analysis of product segments reveals that blueberry production exploded by 50.2%, reaching 27.2 thousand MT, with sales increasing to USD 162.2 million. The targeted pruning strategy emphasized production earlier in the year, leading to enhanced operational efficiency.

Strong Returns from Mangoes and Grapes

This year’s mango segment also performed solidly, achieving a gross profit margin of 36.5% due to excellent field execution, despite a more typical market condition compared to last year’s high prices. Additionally, the grape segment saw a remarkable resurgence with volumes five times higher than the prior year’s first half, recording a staggering 603% rise in revenue.

Financial Management and Returns

Camposol's continued discipline in financial management was evident as short-term debts made up less than 25% of the total, ensuring a resilient capital structure. The company also rewarded shareholders with USD 28.5 million in dividends while investing in key growth initiatives, signaling a proactive approach to future challenges.

Join Us for Upcoming Insights

To engage thoroughly with the company’s financial trajectory, stakeholders are encouraged to participate in the scheduled conference call to discuss these results. Details for registration have been provided in communications to ensure broad participation.

Frequently Asked Questions

What were Camposol’s total sales for the first half of 2025?

Camposol reported total sales of USD 222 million for the first half of 2025.

How does Camposol's Net Debt-to-EBITDA ratio compare to previous quarters?

The Net Debt-to-EBITDA ratio is maintained at 2.59x, below the 3.5x threshold for four consecutive quarters.

What significant certifications did Camposol achieve recently?

Camposol secured an AA+ rating in the BRCGS audit and reinstated its organic certification for Camposol Fresh VB in the Netherlands.

What improvements were noted in the blueberry segment?

Blueberry volumes grew by 50.2% year-over-year, demonstrating strong operational strategy and enhanced efficiency.

Who should potential investors contact for more information?

For more information, potential investors can contact Jossue Yesquen Lihim via email at jyesquen@camposol.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 1

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 1

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 1

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 1

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 0

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elon Musk Critiques Blade Runner 2049 Amid Tesla Lawsuit Turmoil

Updated Category News Views 69

Elon Musk's Take on Blade Runner 2049 Tesla Inc CEO Elon Musk has recently voiced his disapproval of the 2017 film Blade Runner 2049. This remark comes in the wake of a copyright lawsuit that has raised eyebrows within the entertainment and automotive industries. The legal troubles revolve around claims of 'false endorsement' related to imagery used during Tesla's 'We,...

Continue Reading
Trump Hotels Enhances Operations with BirchStreet's ReactorNet

Updated Category News Views 59

Transforming Hotel Operations with ReactorNet BirchStreet's ReactorNet solution marks a significant step forward for Trump Hotels, driving digital transformation across their luxury properties. This partnership leverages advanced procure-to-pay enterprise solutions specifically designed for the hospitality industry, enhancing operational efficiency and simplifying...

Continue Reading
VIP Play, Inc. Expands Horizons with West Virginia Launch Plans

Updated Category News Views 100

VIP Play, Inc. Enters West Virginia Gaming Market VIP Play, Inc. (VIPZ) has recently entered into a noteworthy agreement with Delaware North, paving the way for its entry into the West Virginia market for sports betting and online casino gaming. This strategic partnership is anticipated to bring exciting opportunities to the company and local gaming enthusiasts alike....

Continue Reading
LeveL Markets Rebranding Signals Growth and Innovation Efforts

Updated Category News Views 236

LeveL Markets Unveils New Brand Identity LeveL Markets, LLC, the esteemed broker-dealer and operator of the LeveL and Luminex Alternative Trading Systems, has recently announced a pivotal rebranding initiative. The company officially transitions from its former name, Kezar Markets, to LeveL Markets, a change that is effective immediately. This announcement ushers in a new...

Continue Reading
RxSight Investors Can Take Action for Their Losses Today

Updated Category News Views 137

Opportunity for RxSight, Inc. Investors Investors of RxSight, Inc., particularly those who have suffered significant losses, might find a compelling opportunity on the horizon. A class action lawsuit has been initiated that could potentially provide a pathway for recovery and accountability. This brings a spark of hope to those who invested in RxSight, seeking justice for...

Continue Reading